Further, we dissected the protein expression of SERTAD1 and found SERTAD1 affects chemotherapeutic drug targeting human cancer via synthesized SERTAD1 decoy peptide in nasopharyngeal cancer (CNE2), Cervical cancer (CaSki) and melanoma (MeWo) cancer [3]. This evidence concerns the gene SERTAD1 and nasopharyngeal carcinoma.